Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 195.000 / 992.994K |
Day Range | - - - |
52 Wk Range | 0.891 - 2.090 |
Market Cap | $10.078M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 1.61% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Monopar Therapeutics (NASDAQ:MNPR), Coeptis Therapeutics (NASDAQ:COEP) and Can Fite Biofarma (AMEX:CANF).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1 last updated Today at April 24, 2024 at 4:41 AM EDT.
There are no upcoming dividends for Organovo Holdings.
Organovo Holdings’s Q4 earnings are confirmed for Friday, July 12, 2024.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.